
Fernando Vidal-Ostos De Lara
@FVOdL1
Followers
393
Following
1K
Media
153
Statuses
884
BSc, MD, PhD. Endocrinología y Nutrición Hospital Universitario Príncipe de Asturias. Bioquímico y Médico
Joined March 2012
RT @giorg_kyriakos: 📌 #QWINT-1: Weekly insulin #efsitora vs daily glargine in #T2D (insulin-naïve). 🗓️ 1 vs 7 injections/week.📉 HbA1c: −1.1….
0
12
0
RT @drpablocorral: 👉Managing Dyslipidemia in 2025: The Era of Precision Lipidology. ☝️As we move through 2025, dyslipidemia management has….
0
196
0
RT @cristinatejerap: Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges @Am….
diabetesjournals.org
Sarcopenic obesity, a subtype of obesity, is marked by reduced skeletal muscle mass and function, or sarcopenia, and poses a significant health challenge t
0
6
0
RT @TheLancetEndo: #Incretins and the #cardiovascular system: bridging #digestion with #metabolism .#GLP-1 #GIP htt….
0
36
0
RT @cristinatejerap: Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review @AmDiabetesAssn.
diabetesjournals.org
Until recently, the prevalence of endogenous Cushing syndrome has been considered to be low. However, improved diagnostic strategies and increased awarenes
0
4
0
RT @AntelmPujol: Estas “disrupciones” (eventos que alteran nuestra rutina) van más allá de fiestas:.📦 Cambios de casa.💔 Rupturas.👶 Ser padr….
0
6
0
RT @fjavesc: Covid, celiaquía y polio entran en el listado de crónicas: Sanidad margina de nuevo la obesidad: @Obes….
okdiario.com
Covid, celiaquía y polio entran en el listado de crónicas: la ministra de Sanidad, Mónica García, margina de nuevo la obesidad
0
2
0
RT @Marta_Araujo_C: 🗣️🗣️Me complace compartir con vosotros que el CURSO HTA SECUNDARIA DE ORIGEN ENDOCRINO tendrá lugar el 11 y 18 de novie….
0
28
0
Trends in US Children’s Mortality, Chronic Conditions, Obesity, Functional Status, and Symptoms @SociedadSeedo @sociedadSEEN @ObesitySeen @WorldObesity
0
1
1
RT @CristobMorales: In adults with type 2 diabetes, retatrutide significantly improved total body fat mass reductio….
0
9
0
RT @mdballesteros: GLP-1-derived drugs are just that—drugs—with adverse effects that must be understood and managed. That is why it is esse….
0
13
0
El auge de fármacos para perder peso dispara su demanda y precio, alimentando canales paralelos como el acceso sin control médico desde China o Gibraltar. Riesgo sanitario y falta de regulación en el foco. #Obesidad #SaludPública @ObesitySeen .
eldiario.es
Grupos de WhatsApp para personas en tratamiento con medicamentos como Mounjaro, que no tiene financiación pública, ofrecen compras en la colonia británica que resultan ser falsas o supuestos sutitu...
0
0
2
RT @Paul_Wischmeyer: The urea-to-creatinine ratio as an emerging biomarker in critical care: a scoping review and meta-analysis . 🆕 A new i….
0
83
0
RT @cristinatejerap: Semaglutide in Adults with Type 1 Diabetes and Obesity | NEJM Evidence @NEJM #ADASciSessions #….
evidence.nejm.org
Once-weekly semaglutide is approved for the management of type 2 diabetes and obesity. The efficacy and safety of semaglutide in adults with type 1 diabetes are not established. In this 26-week, do...
0
37
0
RT @CristobMorales: Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes | New England….
0
29
0
CRP reduction with semaglutide is not solely explained by weight loss, waist circumference, insulin or HOMA. This suggests an independent anti-inflammatory effect. #CardiometabolicHealth #Semaglutide.@ObesitySeen @SEDiabetes @SociedadSeedo @CaReMeLO_conf @WorldObesity
0
0
2
Comienza el II Curso de Riesgo Cardiovascular y Diabetes para Residentes en Madrid. Formación clave para abordar la intersección entre metabolismo y salud cardiovascular. #Endocrinología #RiesgoCardiovascular @sociedadSEEN @AMAREVA_Madrid .@SEDiabetes @ObesitySeen
0
0
3